Search research articles
Contact Us
Filters
Showing results (101-110 of 181) with videos related to
Page
of 19
Sort By:
Pediatric Blood & Cancer
|
September 7, 2022
Imaging of pediatric extremity soft tissue tumors: A COG Diagnostic Imaging Committee/SPR Oncology Committee White Paper
Michael Richard Acord, Erika Pace, Alexander El-Ali, et al.
Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine
|
August 14, 2024
Theranostic Intratumoral Convection-Enhanced Delivery of <sup>124</sup>I-Omburtamab in Patients with Diffuse Intrinsic Pontine Glioma: Pharmacokinetics and Lesion Dosimetry
Neeta Pandit-Taskar, Pat B Zanzonico, Milan Grkovski, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
January 26, 2021
Imaging Tumor-Infiltrating Lymphocytes in Brain Tumors with [<sup>64</sup>Cu]Cu-NOTA-anti-CD8 PET
Veronica L Nagle, Kelly E Henry, Charli Ann J Hertz, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
May 3, 2007
Phase I evaluation of J591 as a vascular targeting agent in progressive solid tumors
Michael J Morris, Neeta Pandit-Taskar, Chaitanya R Divgi, et al.
Pediatric Blood & Cancer
|
November 9, 2022
Clinical outcomes of pediatric patients receiving multimodality treatment of second central nervous system relapse of neuroblastoma
Kathryn R Tringale, Suzanne L Wolden, Dana L Casey, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
August 24, 2019
Phase I Trial of Well-Differentiated Neuroendocrine Tumors (NETs) with Radiolabeled Somatostatin Antagonist <sup>177</sup>Lu-Satoreotide Tetraxetan
Diane Reidy-Lagunes, Neeta Pandit-Taskar, Joseph A O'Donoghue, et al.
EJNMMI Research
|
March 7, 2018
I-124 codrituzumab imaging and biodistribution in patients with hepatocellular carcinoma
Jorge A Carrasquillo, Joseph A O'Donoghue, Volkan Beylergil, et al.
Leukemia & Lymphoma
|
August 10, 2011
Bortezomib, liposomal doxorubicin and dexamethasone followed by thalidomide and dexamethasone is an effective treatment for patients with newly diagnosed multiple myeloma with Internatinal Staging System stage II or III, or extramedullary disease
Heather Landau, Neeta Pandit-Taskar, Hani Hassoun, et al.
Cancer
|
June 15, 2013
Repetitively dosed docetaxel and ¹⁵³samarium-EDTMP as an antitumor strategy for metastatic castration-resistant prostate cancer
Karen A Autio, Neeta Pandit-Taskar, Jorge A Carrasquillo, et al.
Health Physics
|
February 25, 2014
Radiation safety considerations for the use of ²²³RaCl₂ DE in men with castration-resistant prostate cancer
Lawrence T Dauer, Matthew J Williamson, John Humm, et al.
Page
of 19
Search research articles
Search
Showing results (101-110 of 181) with videos related to
Sort By:
Page
of 19
Pediatric Blood & Cancer
|
September 7, 2022
Imaging of pediatric extremity soft tissue tumors: A COG Diagnostic Imaging Committee/SPR Oncology Committee White Paper
Michael Richard Acord, Erika Pace, Alexander El-Ali, et al.
Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine
|
August 14, 2024
Theranostic Intratumoral Convection-Enhanced Delivery of <sup>124</sup>I-Omburtamab in Patients with Diffuse Intrinsic Pontine Glioma: Pharmacokinetics and Lesion Dosimetry
Neeta Pandit-Taskar, Pat B Zanzonico, Milan Grkovski, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
January 26, 2021
Imaging Tumor-Infiltrating Lymphocytes in Brain Tumors with [<sup>64</sup>Cu]Cu-NOTA-anti-CD8 PET
Veronica L Nagle, Kelly E Henry, Charli Ann J Hertz, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
May 3, 2007
Phase I evaluation of J591 as a vascular targeting agent in progressive solid tumors
Michael J Morris, Neeta Pandit-Taskar, Chaitanya R Divgi, et al.
Pediatric Blood & Cancer
|
November 9, 2022
Clinical outcomes of pediatric patients receiving multimodality treatment of second central nervous system relapse of neuroblastoma
Kathryn R Tringale, Suzanne L Wolden, Dana L Casey, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
August 24, 2019
Phase I Trial of Well-Differentiated Neuroendocrine Tumors (NETs) with Radiolabeled Somatostatin Antagonist <sup>177</sup>Lu-Satoreotide Tetraxetan
Diane Reidy-Lagunes, Neeta Pandit-Taskar, Joseph A O'Donoghue, et al.
EJNMMI Research
|
March 7, 2018
I-124 codrituzumab imaging and biodistribution in patients with hepatocellular carcinoma
Jorge A Carrasquillo, Joseph A O'Donoghue, Volkan Beylergil, et al.
Leukemia & Lymphoma
|
August 10, 2011
Bortezomib, liposomal doxorubicin and dexamethasone followed by thalidomide and dexamethasone is an effective treatment for patients with newly diagnosed multiple myeloma with Internatinal Staging System stage II or III, or extramedullary disease
Heather Landau, Neeta Pandit-Taskar, Hani Hassoun, et al.
Cancer
|
June 15, 2013
Repetitively dosed docetaxel and ¹⁵³samarium-EDTMP as an antitumor strategy for metastatic castration-resistant prostate cancer
Karen A Autio, Neeta Pandit-Taskar, Jorge A Carrasquillo, et al.
Health Physics
|
February 25, 2014
Radiation safety considerations for the use of ²²³RaCl₂ DE in men with castration-resistant prostate cancer
Lawrence T Dauer, Matthew J Williamson, John Humm, et al.
Page
of 19